Sinovac Biotech Ltd
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000D0D8P5
SVA
Sinovac Biotech Ltd
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Sinovac Biotech Ltd
ISIN
AGP8696W1045
TICKER
SVA
MIC
XNAS
REUTERS
SVA.OQ
BLOOMBERG
SVA US
F&G:
63
Financial Intelligence
FOR INVESTORS
FOR TRADERS
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 10.07.2025
Sinovac Bio
AGP8696W1045
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan an...
Sinovac Bio
Wed, 09.07.2025
Sinovac Bio
AGP8696W1045
SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), today announced that Sinovac Biotech Ltd. (“Sinovac” or the “Company”) shareholders voted to approve SAIF Partners’ proposals to remove the Company’s incumbent directors and to elect SAIF Partners’ slate of ten highly qualified director nominees to the Board of Directors (the “Board”) at Sino...
Sinovac Bio
Wed, 09.07.2025
Sinovac Bio
AGP8696W1045
Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long term shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today announced that the Court of Appeals of the Eastern Caribbean Supreme Court granted a motion to stay the self-interested injunction s...
Sinovac Bio
Wed, 02.07.2025
Sinovac Bio
AGP8696W1045
Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long-term shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today announced that the United States District Court of Massachusetts (“the Court”) granted Vivo’s motion for a preliminary injunction ag...
Sinovac Bio
Wed, 02.07.2025
Sinovac Bio
AGP8696W1045
SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”) which beneficially owns approximately 15% of the Company’s outstanding common shares, today urged shareholders to immediately vote “FOR” the election of SAIF Partners’ ten highly qualified director candidates to ...
Sinovac Bio
Wed, 02.07.2025
Sinovac Bio
AGP8696W1045
Third paragraph, second sentence of release should read: These include the current Board’s failure to actively engage with management, its lack of sound financial reasoning for its proposed dividend figures, its apparent unwillingness to hire a new independent auditor after it drove Sinovac’s prior public accounting firm to resign in April, and it...
Sinovac Bio
Tue, 01.07.2025
Sinovac Bio
AGP8696W1045
SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, today sent a letter to Sinovac shareholders regarding the current Board’s empty promises to shareholders, numerous failures overseeing the Company, and c...
Sinovac Bio
Tue, 24.06.2025
Sinovac Bio
AGP8696W1045
SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, today sent a letter to its fellow Sinovac shareholders exposing the current Sinovac Board’s failure to act in the interest of all shareholders resulting ...
Sinovac Bio
Sun, 22.06.2025
Sinovac Bio
AGP8696W1045
Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of approximately 8% of the Company’s outstanding shares, today issued a statement in response to the decision by the United States District Court for the Southern D...
Sinovac Bio
Wed, 18.06.2025
Sinovac Bio
AGP8696W1045
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang, a member of the board of directors (the “Board”) and a member of the Audit Committee, Compensation Committee and the Corporate Governance and Nomin...
Sinovac Bio
Information on product placements
BARRISTA SMART * AD
P R O D U C T S U G G E S T I O N S
